Dr. John Francis Aloia, M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 222 Station Plz N, Suite 350a, Mineola, NY 11501 Phone: 516-663-3511 Fax: 516-663-4780 |
Amanda Negron, FNP Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 259 1st St, Mineola, NY 11501 Phone: 516-663-0333 |
Michael Goldstein, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 101 Mineola Blvd Fl 2, Mineola, NY 11501 Phone: 516-663-3511 Fax: 516-663-4780 |
Dr. Lawrence Ezra Shapiro, M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 101 Mineola Blvd, 2nd Floor, Mineola, NY 11501 Phone: 516-663-3511 Fax: 516-663-4780 |
Dr. Nushin Khan, M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 222 Station Plz N Ste 509, Mineola, NY 11501 Phone: 516-663-2381 Fax: 516-663-8796 |
Dr. Stanislaw Piotr Klek, M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 101 Mineola Blvd, 2nd Floor, Mineola, NY 11501 Phone: 516-663-3511 |
Dr. Mageda Bishara Mikhail, M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 222 Station Plz N, Suite 350, Mineola, NY 11501 Phone: 516-663-3511 Fax: 516-663-4780 |
Grace Bernaudo, Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 101 Mineola Blvd, Mineola, NY 11501 Phone: 516-663-3511 Fax: 516-663-2308 |
Dr. Gary D Rothberger, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 101 Mineola Blvd, Mineola, NY 11501 Phone: 516-663-0333 |
News Archive
Disease researchers may be able to reduce the time and expense associated with clinical trials, according to early results from the Alzheimer's Disease Neuroimaging Initiative (ADNI), a public-private research partnership organized by the National Institutes of Health.
Researchers from Mount Sinai School of Medicine have developed a new computational method that will help organize scientific data, making it easier for scientists to identify and prioritize genes, drug targets, and connections between drugs. By mining large datasets more simply and efficiently, researchers will be able to better understand gene-gene, protein-protein, and drug/side-effect interactions.
AcuMedSpa Holdings, Inc., in accordance with its vision to increase shareholder value and confidence, announces that it has completed its Authorized Share reduction from 375,000,000 to 175,000,000. The Outstanding Shares remain unchanged at 127,124,965. AcuMedSpa Holdings would like to reiterate its position that it intends to maintain and increase shareholder value.
Today's headlines include news and analysis about the 7 million insurance enrollment tally. Reporting for Kaiser Health News, in partnership with NPR, Eric Whitney writes: "The names of the big health insurance companies are familiar – Blue Cross, Aetna, United Healthcare. But what about CoOportunity Health, or Health Republic Insurance of New York? These are among 23 new health insurance companies that started under the Affordable Care Act.
A new drug has been approved by the FDA in the fight against lung cancer. Tecentriq is being used by patients like Cornelius Bresnan, who had late-stage cancer.
› Verified 1 days ago